Paragonix Technologies, a Cambridge, Mass.-based, organ transplant company, raised $24 million in Series B funding led by Signet Healthcare Partners, per Fortune’s Term Sheet.
Related Posts
Carta Healthcare Secures $25M in Series B
Memorial Hermann Health System and UnityPoint Health led the round.
June 16, 2023